peroxynitric acid has been researched along with Parkinson Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (81.82) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, A; Kawamura, T; Kimura, J; Kitamura, Y; Sawada, H; Shimohama, S; Taniguchi, T | 1 |
| Alam, ZI; Cairns, N; Daniel, SE; Halliwell, B; Jenner, A; Jenner, P; Lees, AJ; Marsden, CD | 1 |
| Dawson, TM; Dawson, VL | 1 |
| Ananda Inalsingh, V; Cammack, R; Hughes, MN; Shergill, JK | 1 |
| Halliwell, B; Jenner, P; Marshall, KA; Reist, M | 1 |
| Guérin, M; Salman-Tabcheh, S; Torreilles, F; Torreilles, J | 1 |
| Heinecke, JW; Jackson-Lewis, V; Pennathur, S; Przedborski, S | 1 |
| Hastings, TG; LaVoie, MJ | 1 |
| Maruyama, W; Naoi, M | 1 |
| Aoyama, K; Fujikawa, Y; Hayase, N; Kobayashi, S; Matsubara, K; Nagahiro, Y; Shimizu, K; Shiono, H; Umegae, N | 1 |
| Carreras, MC; Cherñavsky, A; Gatto, EM; Poderoso, JJ; Riobó, NA; Rubio, A; Satz, ML | 1 |
2 review(s) available for peroxynitric acid and Parkinson Disease
| Article | Year |
|---|---|
Nitric oxide in neurodegeneration.
Topics: AIDS Dementia Complex; Animals; Cerebrovascular Disorders; Humans; Neurodegenerative Diseases; Neurons; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Parkinson Disease | 1998 |
Neurodegenerative disorders: the role of peroxynitrite.
Topics: Alzheimer Disease; Animals; Central Nervous System; Humans; Inflammation; Motor Neuron Disease; Multiple Sclerosis; Neurodegenerative Diseases; Neurons; Nitrates; Oxidants; Parkinson Disease | 1999 |
9 other study(ies) available for peroxynitric acid and Parkinson Disease
| Article | Year |
|---|---|
Mechanism of resistance to NO-induced neurotoxicity in cultured rat dopaminergic neurons.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Ascorbic Acid; Cell Survival; Cells, Cultured; Dopamine; Drug Resistance; Mesencephalon; Nerve Tissue Proteins; Neurons; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Oxidation-Reduction; Parkinson Disease; Rats; Tyrosine 3-Monooxygenase | 1996 |
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.
Topics: Aged; Aged, 80 and over; Aging; Base Composition; DNA; DNA Damage; Gas Chromatography-Mass Spectrometry; Guanine; Humans; Hydroxyl Radical; Middle Aged; Nitrates; Oxidants; Oxidation-Reduction; Parkinson Disease; Pyrimidines; Reference Values; Regression Analysis; Substantia Nigra | 1997 |
Applications of electron paramagnetic resonance spectroscopy to study interactions of iron proteins in cells with nitric oxide.
Topics: Animals; Bacteria; Cysteine; Electron Spin Resonance Spectroscopy; Food Preservation; Hemeproteins; Hemoglobins; Mammals; Mitochondria, Liver; Nitrates; Nitric Oxide; Nitrites; Nitroprusside; Parkinson Disease; Shock, Septic; Substantia Nigra | 1998 |
The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: implications for Parkinson's disease.
Topics: Animals; Cell Line; Cell Survival; Glutathione; Neurons; Nitrates; Parkinson Disease; Rats; Substantia Nigra; Sulfites; Tetrazolium Salts; Time Factors | 1999 |
Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Brain; Chelating Agents; Dopamine Agents; Free Radicals; Gas Chromatography-Mass Spectrometry; Male; Mice; Mice, Inbred C57BL; Nitrates; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Pentetic Acid; Tissue Distribution; Tyrosine | 1999 |
Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alcohol Dehydrogenase; Antioxidants; Apoptosis; Catalase; Chromatography, High Pressure Liquid; Dopamine; Hydrogen-Ion Concentration; Methamphetamine; Monophenol Monooxygenase; Nerve Tissue Proteins; Neurons; Nitrates; Nitric Oxide; Nitrites; Oxidants; Oxidation-Reduction; Parkinson Disease; Protein Binding; Sulfhydryl Compounds; Superoxide Dismutase | 1999 |
Neuroprotection by (-)-deprenyl and related compounds.
Topics: Aging; Amphetamines; Animals; Antioxidants; Apoptosis; Cattle; DNA Damage; DNA, Neoplasm; Indans; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Nitrates; Oxidants; Parkinson Disease; Selegiline; Tumor Cells, Cultured | 1999 |
Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases.
Topics: Adult; Aged; Alzheimer Disease; Antibodies; Biomarkers; Female; Humans; Male; Middle Aged; Nitrates; Nitrogen; Oxidative Stress; Parkinson Disease; Precipitin Tests; Superoxide Dismutase; Tyrosine | 2000 |
Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's disease.
Topics: Blotting, Western; Enzyme Induction; Female; Humans; Hydrogen Peroxide; Male; Middle Aged; Neutrophils; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Parkinson Disease; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrophotometry; Tyrosine | 2000 |